Atjaunināt sīkdatņu piekrišanu

E-grāmata: Hepatitis B Vaccines in Clinical Practice

  • Formāts: 438 pages
  • Sērija : Infectious Disease and Therapy
  • Izdošanas datums: 01-Nov-2024
  • Izdevniecība: CRC Press Inc
  • Valoda: eng
  • ISBN-13: 9781040290491
  • Formāts - PDF+DRM
  • Cena: 407,00 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Bibliotēkām
  • Formāts: 438 pages
  • Sērija : Infectious Disease and Therapy
  • Izdošanas datums: 01-Nov-2024
  • Izdevniecība: CRC Press Inc
  • Valoda: eng
  • ISBN-13: 9781040290491

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Toward the goal of eradicating one of the world's most prevalent infectious diseases, a comprehensive reference on the vaccines their development, production, and use; serological assays; epidemiology; clinical trials in various countries and among various populations; needs unfulfilled by current vaccines; variant viruses; experimental HBV vaccine design; and potential future recombinant vaccines. Of particular interest to pediatricians and clinical practitioners are the current recommendations for vaccination including the American Academy of Pediatrics recommendation for universal vaccination of infants, and new OSHA regulations covering many types of workers. Annotation copyright Book News, Inc. Portland, Or.

This book presents current recommendations for vaccination for pre- and post-exposure prophylaxis in all suitable target populations and groups. It provides immunization guidelines from the Occupational Safety and Health Administration for health care workers and others at occupational risk of exposure and for routine vaccinations by the Immune Practices Advisory Committee of the Centers for Disease Control.;Covering all aspects of the production, testing and applications of Hepatitis B vaccines, this book: lists all available vaccines worldwide; discusses all serological assays in the field; examines how the vaccine was tested in international clinical trials; describes new programmes for universal immunization of infants; and reveals how the vaccine may prevent some forms of hepatocellular carcinoma.;The book should be of interest to: infectious disease specialists, clinical virologists, immunologists, haematologists, oncologists, hepatologists and gastroenterologists, paediatricians, pharmacologists, molecular biologists, biochemists, biotechnologists, genetic engineers, occupational safety administrators and public health specialists; and upper level undergraduate, graduate and medical school students of these disciplines.
Recommendations for prevention of hepatitis B with vaccine, Gary B. Calandra and David J. West; plasma-derived hepatitis B vaccine - a breakthrough in preventive medicine, Maurice R. Hilleman; functions of hepatitis B virus proteins and molecular targets for protective immunity, Wolfram H. Gerlich and Volker Bruss; survey of licensed hepatitis B vaccines and their production processes, Robert D. Sitrin et al; quality control of hepatitis B vaccine, Victor P. Grachev and David I. Magrath; serological assays, William J. Miller; epidemiology of hepatitis B virus infection, Stephen C. Hadler and Harold S. Margolis; scope and design of hepatitis B vaccine clinical trials, David J. West; overview of clinical trials in low-endemic areas, Catherine L. Troisi and F. Blaine Hollinger; overview of clinical studies in developing countries, Pierre Coursaget and Mark A. Kane; hepatitis B vaccination - overview of clinical studies in the Far East, E.K. Yeoh and Betty Young; protective efficacy of hepatitis B vaccines in infants, children and adults, Brian J. McMahon and Robert B. Wainwright; prevention of hepatocellular carcinoma, Juei-Low Sung et al; hepatitis B vaccination of children in endemic areas, Alexander Milne and Christopher D. Moyes; prevention of hepatitis B virus infection among health-care workers, Eric E. Mast and Miriam J. Alter; global control of hepatitis B through universal infant immunization, Mark A. Kane; needs unfulfilled by current hepatitis B vaccines, Patricia L. Hibberd et al; variant hepatitis B and D viruses, Tim J. Harrison and Arie J. Zuckerman; application of synthetic peptide technology to experimental hepatitis B vaccine design, David R. Milich; potential future recombinant vaccines, Tineke Rutgers et al.
Ronald W. Ellis